Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain

THE protein Tat is encoded by the HIV-1 genome and is essential for viral replication because of its activation of viral transcription. Tat enhances the ability of RNA polymerase II (Pol II) to move long distances down the DNA through a poorly understood mechanism that involves its binding the to the 5' end of the nascent HIV-1 transcript1–5. It has been suggested6–10 that the stimulation of transcript elongation by conventional DNA-binding activators may involve phosphorylation of the carboxy-terminal domain (CTD) of Pol II by the transcription factor TFIIH11–13 through the associated CAK kinase14–16. Here we show that Tat-enhanced HIV-1 transcription in vitro requires both TFIIH and the CTD of Pol II. In addition, Tat, through its activation domain, both interacts with a functional TFIIH-containing complex and stimulates phosphorylation of a CTD-containing substrate by the TFIIH kinase. Under conditions that jointly restrict transcriptional elongation5,17 and TFIIH-mediated CTD phosphorylation, Tat stimulates both these activities. Furthermore, RNA synthesis is required for Tat to stimulate phosphorylation of the CTD when it is part of an initiation complex, as expected from Tat's interaction with viral transcripts1. Thus, stimulation of Pol II elongation by Tat may involve direct effects on TFIIH-mediated CTD phosphorylation.

[1]  M. Mathews,et al.  HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation , 1989, Cell.

[2]  P. Sharp,et al.  HIV‐1 Tat protein promotes formation of more‐processive elongation complexes. , 1991, The EMBO journal.

[3]  D. Reinberg,et al.  Role of the mammalian transcription factors IIF, IIS, and IIX during elongation by RNA polymerase II , 1991, Molecular and cellular biology.

[4]  D. Baltimore,et al.  The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Reinberg,et al.  Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II , 1992, Nature.

[6]  C. Anderson,et al.  DNA binding provides a signal for phosphorylation of the RNA polymerase II heptapeptide repeats. , 1992, Genes & development.

[7]  R. Roeder,et al.  HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. , 1992, Genes & development.

[8]  M. Malim,et al.  The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. , 1992, Genes & development.

[9]  R. Conaway,et al.  Phosphorylation of C-terminal domain of RNA polymerase II is not required in basal transcription , 1993, Nature.

[10]  B. Cullen,et al.  Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function , 1993, Journal of virology.

[11]  R. Roeder,et al.  Regulation of TFIIH ATPase and kinase activities by TFIIE during active initiation complex formation , 1994, Nature.

[12]  D. Reinberg,et al.  Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53 , 1994, Molecular and cellular biology.

[13]  D. Bentley,et al.  Transcriptional elongation by RNA polymerase II is stimulated by transactivators , 1994, Cell.

[14]  J. Hoeijmakers,et al.  The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor , 1994, Cell.

[15]  B. Peterlin,et al.  Control of RNA initiation and elongation at the HIV-1 promoter. , 1994, Annual review of biochemistry.

[16]  R. Tjian,et al.  Transcription factors IIE and IIH and ATP hydrolysis direct promoter clearance by RNA polymerase II , 1994, Cell.

[17]  R. Roeder,et al.  A Novel LBP-1-mediated Restriction of HIV-1 Transcription at the Level of Elongation in Vitro(*) , 1995, The Journal of Biological Chemistry.

[18]  P. Sharp,et al.  Novel mechanism and factor for regulation by HIV‐1 Tat. , 1995, The EMBO journal.

[19]  D. Reinberg,et al.  Cdk-activating kinase complex is a component of human transcription factor TFIIH , 1995, Nature.

[20]  R. Young,et al.  Association of Cdk-activating kinase subunits with transcription factor TFIIH , 1995, Nature.

[21]  M. Horikoshi,et al.  Analysis of the role of TFIIE in basal transcription and TFIIH-mediated carboxy-terminal domain phosphorylation through structure-function studies of TFIIE-alpha , 1995, Molecular and cellular biology.

[22]  D. Bentley,et al.  The Transcriptional Elongation Inhibitor 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole Inhibits Transcription Factor IIH-associated Protein Kinase (*) , 1995, The Journal of Biological Chemistry.

[23]  R. Gaynor,et al.  Identification of a Group of Cellular Cofactors That Stimulate the Binding of RNA Polymerase II and TRP-185 to Human Immunodeficiency Virus 1 TAR RNA (*) , 1996, The Journal of Biological Chemistry.

[24]  R. Conaway,et al.  A Role for ATP and TFIIH in Activation of the RNA Polymerase II Preinitiation Complex Prior to Transcription Initiation (*) , 1996, The Journal of Biological Chemistry.

[25]  The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. , 1996, Journal of virology.

[26]  J. Greenblatt,et al.  Three functional classes of transcriptional activation domain , 1996, Molecular and cellular biology.

[27]  B. Cullen,et al.  Synergistic enhancement of both initiation and elongation by acidic transcription activation domains. , 1996, The EMBO journal.

[28]  A. Rice,et al.  Viral transactivators specifically target distinct cellular protein kinases that phosphorylate the RNA polymerase II C-terminal domain. , 1996, Nucleic acids research.

[29]  Ming Yan,et al.  A three-step pathway of transcription initiation leading to promoter clearance at an activation RNA polymerase II promoter , 1996, Molecular and cellular biology.

[30]  F. Holstege,et al.  Opening of an RNA polymerase II promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH. , 1996, The EMBO journal.